Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 291

    1.

    A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.

    Bhatwadekar A, Glenn JV, Figarola JL, Scott S, Gardiner TA, Rahbar S, Stitt AW.

    Br J Ophthalmol. 2008 Apr;92(4):545-7. Epub 2008 Jan 22.PMID: 18211931 [PubMed - indexed for MEDLINE]Related articles

    2.

    Novel inhibitors of glycation and AGE formation.

    Rahbar S.

    Cell Biochem Biophys. 2007;48(2-3):147-57.PMID: 17709884 [PubMed - indexed for MEDLINE]Related articles

    3.

    LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

    Figarola JL, Scott S, Loera S, Tessler C, Chu P, Weiss L, Hardy J, Rahbar S.

    Diabetologia. 2003 Aug;46(8):1140-52. Epub 2003 Jul 5.PMID: 12845431 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.

    Yatoh S, Mizutani M, Yokoo T, Kozawa T, Sone H, Toyoshima H, Suzuki S, Shimano H, Kawakami Y, Okuda Y, Yamada N.

    Diabetes Metab Res Rev. 2006 Jan-Feb;22(1):38-45.PMID: 15892182 [PubMed - indexed for MEDLINE]Related articles

    5.

    The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

    Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR.

    Diabetes. 2002 Sep;51(9):2826-32. Erratum in: Diabetes 2003 Jan;52(1):223. Anderson Nathan L [corrected to Alderson Nathan L]. PMID: 12196477 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.

    Gardiner TA, Anderson HR, Stitt AW.

    J Pathol. 2003 Oct;201(2):328-33.PMID: 14517851 [PubMed - indexed for MEDLINE]Related articles

    7.

    Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

    Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.PMID: 11053301 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug.

    Gardiner TA, Anderson HR, Degenhardt T, Thorpe SR, Baynes JW, Archer DB, Stitt AW.

    Diabetologia. 2003 Sep;46(9):1269-75. Epub 2003 Jul 12.PMID: 12861449 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine.

    Hammes HP, Bartmann A, Engel L, Wülfroth P.

    Diabetologia. 1997 Jun;40(6):629-34.PMID: 9222640 [PubMed - indexed for MEDLINE]Related articles

    10.

    Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.

    Hammes HP, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K.

    Diabetologia. 1994 Jan;37(1):32-5.PMID: 8150227 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.

    Figarola JL, Scott S, Loera S, Xi B, Synold T, Weiss L, Rahbar S.

    Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):533-44.PMID: 15818713 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.

    Agardh E, Hultberg B, Agardh C.

    Curr Eye Res. 2000 Jul;21(1):543-9.PMID: 11035534 [PubMed - indexed for MEDLINE]Related articles

    13.

    Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.

    Figarola JL, Scott S, Loera S, Xi B, Synold T, Rahbar S.

    Ann N Y Acad Sci. 2005 Jun;1043:767-76.PMID: 16037304 [PubMed - indexed for MEDLINE]Related articles

    14.

    Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.

    Hammes HP, Strödter D, Weiss A, Bretzel RG, Federlin K, Brownlee M.

    Diabetologia. 1995 Jun;38(6):656-60.PMID: 7672485 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.

    Kern TS, Engerman RL.

    Diabetes. 2001 Jul;50(7):1636-42.PMID: 11423486 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

    Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M.

    Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11555-8. Erratum in: Proc Natl Acad Sci U S A 1992 Oct 1;89(19):9364. PMID: 1763069 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.

    Hammes HP, Ali SS, Uhlmann M, Weiss A, Federlin K, Geisen K, Brownlee M.

    Diabetologia. 1995 Mar;38(3):269-73.PMID: 7758871 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.

    Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT.

    Am J Pathol. 2008 May;172(5):1411-8. Epub 2008 Apr 10.PMID: 18403591 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.

    Padilla E, Ganado P, Sanz M, Zeini M, Ruiz E, Triviño A, Ramírez AI, Salazar JJ, Ramírez JM, Rojas B, Hoz R, Tejerina T.

    Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):132-42.PMID: 15386814 [PubMed - indexed for MEDLINE]Related articles

    20.

    Renoprotective effects of a novel inhibitor of advanced glycation.

    Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper ME.

    Diabetologia. 2001 Jan;44(1):108-14.PMID: 11206401 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data